ExodusPoint Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
+45,255
| New | +$593K | 0.01% | 1042 |
|
|
2024
Q3 | – | Sell |
-268,143
| Closed | -$4.83M | – | 1617 |
|
|
2024
Q2 | $4.83M | Buy |
+268,143
| New | +$4.83M | 0.03% | 375 |
|
|
2023
Q3 | – | Sell |
-138,227
| Closed | -$1.07M | – | 1751 |
|
|
2023
Q2 | $1.07M | Sell |
138,227
-3,624
| -3% | -$28.1K | 0.01% | 990 |
|
|
2023
Q1 | $946K | Buy |
141,851
+23,901
| +20% | +$159K | 0.01% | 1061 |
|
|
2022
Q4 | $1.05M | Buy |
117,950
+432
| +0.4% | +$3.86K | 0.02% | 895 |
|
|
2022
Q3 | $1.16M | Buy |
117,518
+57,490
| +96% | +$566K | 0.02% | 1020 |
|
|
2022
Q2 | $478K | Buy |
+60,028
| New | +$478K | 0.01% | 1332 |
|